Bone Mineral Density After Simultaneous Kidney–Pancreas Transplantation: Four Years Follow-up of 57 Recipients

Bone disease and an high risk of fractures are major problems in transplantation. Among diabetic patients undergoing simultaneous kidney–pancreas (SKP) transplantation, there are few studies assessing long-term effects on bone mass. The aim of this study was to evaluate bone mineral density (BMD) ov...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 42; no. 2; pp. 555 - 557
Main Authors Pereira, S., Pedroso, S., Martins, L., Santos, P., Almeida, M., Freitas, C., Dias, L., Dores, J., Almeida, R., Castro Henriques, A., Teixeira, M.
Format Journal Article Conference Proceeding
LanguageEnglish
Published Amsterdam Elsevier Inc 01.03.2010
Elsevier
Subjects
Online AccessGet full text
ISSN0041-1345
1873-2623
1873-2623
DOI10.1016/j.transproceed.2010.01.046

Cover

More Information
Summary:Bone disease and an high risk of fractures are major problems in transplantation. Among diabetic patients undergoing simultaneous kidney–pancreas (SKP) transplantation, there are few studies assessing long-term effects on bone mass. The aim of this study was to evaluate bone mineral density (BMD) over 4 years follow-up after SKP transplantation. Fifty-seven patients had 22.8 ± 5.3 years of prior diabetes, 65% were female, and the overall mean age was 24.3 ± 5.93 years. At the time of transplantation, the lumbar spine and femoral neck T-scores were −1.75 ± 1.05 and −1.95 ± 0.73, respectively; 28% of subjects had evidence of osteoporosis. One year after transplantation, 77.6% of patients displayed improved lumbar T-scores to −1.33 ± 0.94 ( P = .044) with stable femoral neck T-scores. Bone densitometry enhanced gradually through the 4 years follow-up: lumbar T-score to −1.04 ± 0.67 ( P = .004) and femoral neck T-score to −1.69 ± 0.49 ( P = .12). At year 4, no osteoporosis cases were detected but 86.7% of patients did not receive steroids in the immunosuppressive regimen. The graft function remained stable (serum creatinine, 1.2 mg/dL; fasting glucose, 87.7 mg/dL). During the follow-up, BMD improved more significantly at cortical sites. Our study reports a reduced prevalence of fractures (8.7%) compared with the literature, which could be related to a steroid-sparing protocol and/or aggressively treatment of osteoporosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
1873-2623
DOI:10.1016/j.transproceed.2010.01.046